Towards personalized treatment for early stage HER2-positive breast cancer
Advances in HER2-targeted therapies have improved the survival of patients with HER2-positive breast cancer. The standard-of-care treatment for …
Nazneen Rahman flipped this story into Medical Innovations•1568d